NEW ORLEANS, March 28, 2026 – Merge, a leader in Enterprise Imaging, will showcase its award-winning cardiology solutions at the American College of Cardiology (ACC) Annual Scientific Session & Expo from March 28–30, 2026, in New Orleans. At booth #929, Merge will feature live demonstrations of Merge Cardio and Merge Hemo, recognized market-leading tools drawing on innovative AI integrations and Best in KLAS ranked hemodynamic monitoring to enhance clinical decision-making and make cardiovascular service lines more productive, cost-effective, and patient-centered.
Merge arrives at ACC 2026 following the recognition of Merge Hemo as the 2026 Best in KLAS winner for cardiology hemodynamics. The latest version of the solution, Merge Hemo 11.2, delivers significant enhancements to cath lab teams, including Windows 11 LTSC support, streamlined IT update deployments, robust cybersecurity protections, and new Nellcor SpO2 monitoring device compatibility. These updates provide a more flexible, secure, and comprehensive patient monitoring experience for care teams.
In addition to winning the top honor for Merge Hemo, Merge Cardio was ranked by KLAS as among the top three for Cardiology monitoring solutions. A 10-year Best in KLAS winner, the latest release, Merge Cardio 12.5, empowers cardiology imaging teams with new FDA cleared AI measurement streamlining capabilities integrated from partner Us2.ai. These features, directly plugged into the product for seamless use, provide AI-generated echocardiogram measurements that can help save time and take variability out of the equation – making echocardiographic measurements more consistent, reproducible, and less tedious for clinicians. Additional quality of life updates, including streamlined workflows and optimized workstation measurements, support timely, consistent clinical reporting and boost clinician confidence.
“'Reliable imaging. Less complexity. Better care.’ That is the vision Merge brings to the cardiology space, with seamless solutions that help cardiology imaging teams eliminate time-wasting steps so they can spend more of their day on image interpretation and patient care,” said Ashish Sant, Executive Vice President and General Manager of Merge. “By leveraging cutting-edge AI capabilities from our partners at Us.2ai, Merge is automating cardiology measurements and report generation, so that these care teams can enjoy faster workflows and act with greater confidence and efficiency. We invite ACC attendees to experience this firsthand at our booth.”
Attendees can visit booth #929 for demos of Merge Cardio 12.5 and Merge Hemo 11.2, along with live, interactive demonstrations of the tight AI integration Merge Cardio has with partner Us2.ai. To schedule a personalized demo, visit https://www.merative.com/events/acc-2026.
Merge empowers healthcare organizations with advanced medical imaging solutions to deliver reliable imaging, less complexity, and better care. Merge is trusted by 6 of the 10 largest U.S. health systems. Merge’s Imaging Suite, built on a cloud-native foundation, provides capabilities for Vendor-Neutral Archive (VNA) for secure, enterprise-wide data management; Enterprise Diagnostic Viewing for anytime, anywhere image access; and Workflow Orchestration to streamline imaging workflows with AI-powered caseload management. Merge’s portfolio also includes PACS for multi-specialty support and advanced mammography capabilities, Cardiology solutions for improved hemodynamics workflows and comprehensive CVIS support, and support for Digital Pathology. Learn more at merative.com/merge-imaging.